IRD – opus genetics, inc. (US:NASDAQ)

News

Opus Genetics: Asymmetric Upside With LCA5 And BEST1 [Seeking Alpha]
Update: Opus Genetics Shares Rise After Announcement of $25 Million Private Placement [Yahoo! Finance]
Opus Genetics Announces $25 Million Private Placement
Opus Genetics (NASDAQ:IRD) was upgraded by analysts at Lifesci Capital to a "strong-buy" rating.
Opus Genetics to Participate in Upcoming Medical and Industry Conferences in February 2026
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com